LearnGlossaryMarketStocksSuperinvestorsSign in

BLFS

BioLife Solutions, Inc.

Healthcare · $1.9B market cap

Verdict

We can't put a fair value on BLFS right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.

Business quality

2 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth27.3% a year✓
Sales growth27.2% a year✓
Free cash flow growth8.0% a year✗
Return on invested capital-2.4%✗

Follow BLFS

Track it on your watchlist and see the full analysis. Free.

Create a free account

Insider activity

Since Sep 8, 2026: no open-market purchases and 3 other filings (stock awards, tax withholding and similar). Why purchases matter

Other filings

Wichterman Troy

Chief Financial Officer · 2026-09-08

Tax withholding

$36K

Mathew Aby J.

EVP & Chief Scientific Officer · 2026-09-08

Tax withholding

$22K

Berard Todd

Chief Marketing Officer · 2026-09-08

Tax withholding

$13K

About BioLife Solutions, Inc.

BioLife Solutions, Inc. (BLFS) operates as a global provider of specialized bioproduction tools and services, primarily catering to the cell and gene therapy industry. Its market reach extends across the United States, Canada, Europe, the Middle East, Africa, and other international regions. The company's offerings are essential for various stages of biologic-based therapy development, spanning from foundational and…

Medical - Instruments & Supplies

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works